ODTX — Odyssey Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual balance sheet for Odyssey Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.241	187	129	181
Prepaid Expenses
Total Current Assets	0.249	193	136	191
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.053	46.7	39.5	26
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	0.317	287	197	270
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.023	22.1	28.4	26.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.07	61	65.1	54.5
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.247	225	132	215
Total Liabilities & Shareholders' Equity	0.317	287	197	270
Total Common Shares Outstanding